p.142 抽出テキスト

augmented peripheral chemosensitivity. Circulation 1999; 100: 2418-2424. 8)Brack T, Thuer I, Clarenbach CF, et al: Daytime Cheyne- Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 2007; 132: 1463-1471. 9)Poletti R, Passino C, Giannoni A, et al: Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients. Int J Cardiol 2009; 137: 47-53. 10)Tamura A, Kawano Y, Kadota J: Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J 2009; 73: 295-298. 11)Yamamoto U, Mohri M, Shimada K, et al: Six-month aerobic exercise training ameliorates central sleep apnea in patients with chronic heart failure. J Card Fail 2007; 13: 825-829. 12)Lamba J, Simpson CS, Redfearn DP, et al: Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 2011; 13: 1174-1179. 13)Mansfield DR, Solin P, Roebuck T, et al: The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 2003; 124: 1675-1681. 14)Javaheri S, Parker TJ, Wexler L, et al: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335: 562-567. 15)Lorenzi-Filho G, Rankin F, Bies I, et al: Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999; 159: 1490-1498. 16)Khayat RN, Xie A, Patel AK, et al: Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 2003; 123: 1551-1560. 17)Andreas S, Weidel K, Hagenah G, et al: Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J 1998; 12: 414-419. 18)Javaheri S: Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006; 173: 234-237. 19)Ponikowski P, Javaheri S, Michalkiewicz D, et al: Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J 2012; 33: 889-894. 20)Zhang XL, Ding N, Wang H, et al: Transvenous phrenic nerve stimulation in patients with Cheyne-Stokes respiration and congestive heart failure: a safety and proofof-concept study. Chest 2012; 142: 927-934. 21)Andreas S, Clemens C, Sandholzer H, et al: Improvement of exercise capacity with treatment of Cheyne- Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27: 1486-1490. 22)Hanly PJ, Millar TW, Steljes DG, et al: The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989; 111: 777-782. 23)Krachman SL, D’Alonzo GE, Berger TJ, et al: Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999; 116: 1550- 1557. 24)Staniforth AD, Kinnear WJ, Starling R, et al: Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19: 922-928. 25)Sasayama S, Izumi T, Seino Y, et al: Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J 2006; 70: 1-7. 26)Sasayama S, Izumi T, Matsuzaki M, et al: Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J 2009; 73: 1255-1262. 27)Arzt M, Bradley TD: Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006; 173: 1300-1308. 28)Naughton MT, Liu PP, Bernard DC, et al: Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151: 92-97. 29)Sin DD, Logan AG, Fitzgerald FS, et al: Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-66. 30)Bradley TD, Logan AG, Kimoff RJ, et al: Continuous

positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033. 31)Arzt M, Floras JS, Logan AG, et al: Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP) .Circulation 2007; 115: 3173-3180. 32)Noda A, Izawa H, Asano H, et al: Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea-hypopnea: a preliminary study. Chest 2007; 131: 1694-1701. 33)Kasai T, Narui K, Dohi T, et al: Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with cheyne-stokes respiration and central sleep apnea. Circ J 2005; 69: 913-921. 34)Dohi T, Kasai T, Narui K, et al: Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J 2008; 72: 1100-1105. 35)Teschler H, Dohring J, Wang YM, et al: Adaptive pressure support servo-ventilation: a novel treatment for